School of Medicine
Medical tablets, capsules and caplets flying out of a bottle against a light blue background

News and updates

From eyedrops to potential leukaemia treatment

Description
An active ingredient in eye drops that were being developed by experts in Nottingham has shown promise for treating an aggressive form of blood cancer, research has shown.
Date:
20/12/2018

Patient power sets top research priorities for lichen sclerosus

Description
People with a distressing skin condition, lichen sclerosus, have helped dermatologists set the top 10 priorities for future medical research into the disease.
Date:
18/12/2018

Could cancer anti-sickness drug end the misery for IBS patients?

Description
A nationwide clinical trial is to investigate whether a commonly-prescribed anti-sickness drug could be the answer for the 1.3 million people in the UK who suffer the pain and misery of irritable bowel syndrome with diarrhoea (IBS-D).
Date:
18/12/2018

New genetic study could lead to better treatment of severe asthma

Description
The largest-ever genetic study of people with moderate-to-severe asthma has revealed new insights into the underlying causes of the disease which could help improve its diagnosis and treatment.
Date:
12/12/2018

£1.5m study to test diagnostic tool for child and adolescent mental health

Description
A diagnostic tool, which can be used by mental health clinicians to assess children and teenagers, is to be evaluated by experts from the University of Nottingham and Institute of Mental Health, thanks to a £1.5m NIHR grant.
Date:
11/12/2018

Blast off for first UK-led experiment on the International Space Station

Description
UK-led research is taking place on the International Space Station (ISS) for the first time, following a successful launch from Kennedy Space Centre at Cape Canaveral in the US.
Date:
06/12/2018
Displaying 91 to 100 of 100
Previous … 6 7 8 9 10 Next

School of Medicine

University of Nottingham
Medical School
Nottingham, NG7 2UH

Contacts: Call 0115 823 0031 ext.30031 or please see our 'contact us' page for further details